| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |